Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AurumRabosa who wrote (835)	3/30/2000 3:12:00 AM
From: tuck	Read Replies (1) of 1298

Hi, Ron, It's not the arbitrage that's attractive wrt CEGE by itself. It's the fact that a stake in a hot company can be moved quickly. CEGE is in position to sell shares of ABGX whenever a good opportunity -- such as this February's mo-mo spike -- arises. By contrast, a company like ABSC that can only sell it's own shares, must do so via a time consuming follow-on. ABSC thus missed this window and withdrew its follow-on. The ability to hedge CEGE against AMGN via the patent/royalty situation is icing on the cake. The cake itself is the fundamentals you mentioned, and the ABGX shares are the candles. Add match and . . . Bon Appetit! Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next